Novel pathogenic mutations and copy number variations in the VPS13A Gene in patients with chorea‐acanthocytosis
暂无分享,去创建一个
K. Kotschet | D. Babovic‐Vuksanovic | K. Wakabayashi | S. Orimo | N. Dupré | K. Josephs | S. Saiki | H. Ujike | J. Aasly | M. Rudzińska | K. Tojo | A. Szczudlik | Tatsuo Yamada | A. Sano | Hidetaka Yamada | S. Penco | J. Kobal | S. Ueno | T. Inui | Masayuki Nakamura | M. Morimoto | Z. Afawi | M. Ichiba | F. Yokochi | I. Blatt | Akiyuki Tomiyasu | G. Rodrigues | Y. Kageyama | Yuji Kanemori | H. Jung | Rie Tohge | T. Takei | Haruhiko Tanaka | H. Yamada | M. Fujiwara
[1] A. Danek,et al. Mutation in the CHAC gene in a family of autosomal dominant chorea–acanthocytosis , 2012, Neurology.
[2] 富安 昭之. Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosis , 2011 .
[3] K. Wakabayashi,et al. Chorea-acanthocytosis with upper motor neuron degeneration and 3419_3420 delCA and 3970_3973 delAGTC VPS13A mutations , 2010, Acta Neuropathologica.
[4] T. de Ravel,et al. Deletions in the VPS13B (COH1) gene as a cause of Cohen syndrome , 2009, Human mutation.
[5] J. Lupski,et al. Mechanisms for human genomic rearrangements , 2008, PathoGenetics.
[6] A. Danek,et al. Mutation analysis of Parkin, PINK1, DJ‐1 and ATP13A2 genes in Chinese patients with autosomal recessive early‐onset Parkinsonism , 2008, Movement disorders : official journal of the Movement Disorder Society.
[7] G. Hirose. Neuroacanthocytosis in Japan — Review of the Literature and Cases , 2008 .
[8] S. Saiki,et al. Reply: chorea-acanthocytosis with an autosomal-dominant trait , 2008, Acta Neuropathologica.
[9] A. Danek,et al. Dominant transmission of chorea-acanthocytosis with VPS13A mutations remains speculative , 2008, Acta Neuropathologica.
[10] S. Saiki,et al. A neuropathological study of autosomal-dominant chorea-acanthocytosis with a mutation of VPS13A , 2008, Acta Neuropathologica.
[11] A. Sano,et al. Clinical and molecular genetic assessment of a chorea-acanthocytosis pedigree , 2007, Journal of the Neurological Sciences.
[12] Keiji Matsumoto,et al. A new phenotype of chorea‐acanthocytosis with dilated cardiomyopathy and myopathy , 2007, Movement disorders : official journal of the Movement Disorder Society.
[13] A. Danek,et al. Neurologic phenotypes associated with acanthocytosis , 2007, Neurology.
[14] A. Monaco,et al. Identification of a VPS13A founder mutation in French Canadian families with chorea-acanthocytosis , 2005, Neurogenetics.
[15] J. Mendell,et al. Mutation rates in the dystrophin gene: A hotspot of mutation at a CpG dinucleotide , 2005, Human mutation.
[16] Daisuke Sato,et al. A gene‐targeted mouse model for chorea‐acanthocytosis , 2005, Journal of neurochemistry.
[17] A. Monaco,et al. Chorein detection for the diagnosis of chorea‐acanthocytosis , 2004, Annals of neurology.
[18] S. Saiki,et al. Mutation in the CHAC gene in a family of autosomal dominant chorea–acanthocytosis , 2003, Neurology.
[19] A. Monaco,et al. Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis , 2002, European Journal of Human Genetics.
[20] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[21] A. Lang,et al. The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. , 2001, Human molecular genetics.
[22] Y. Maruki,et al. The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis , 2001, Nature Genetics.
[23] Adrian Danek,et al. A conserved sorting-associated protein is mutant in chorea-acanthocytosis , 2001, Nature Genetics.
[24] J. Weissenbach,et al. Characterization of the NPHP1 locus: mutational mechanism involved in deletions in familial juvenile nephronophthisis. , 2000, American journal of human genetics.
[25] J. Dodge,et al. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. , 1963, Archives of biochemistry and biophysics.